Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C

D. Theodore, M. W. Fried, D. E. Kleiner, B. L. Kroner, J. J. Goedert, M. E. Eyster, S. P. Faust, K. E. Sherman, C. M. Kessler, C. Francis, Louis M. Aledort

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Liver biopsy plays a pivotal role in the management of patients with a variety of liver diseases, including chronic hepatitis C virus. The major risk of the procedure is the potential for significant haemorrhagic complications. Although the data are limited, the procedure does not appear to pose excessive risk to the patient with inherited disorders of coagulation, provided that adequate haemostasis can be achieved prior to the liver biopsy. This requires close coordination of care between the hepatologist and the haematologist. Indications for liver biopsy should be the same in patients with haemophilia as in other populations.

Original languageEnglish (US)
Pages (from-to)413-421
Number of pages9
JournalHaemophilia
Volume10
Issue number5
DOIs
StatePublished - Sep 2004

All Science Journal Classification (ASJC) codes

  • Hematology
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C'. Together they form a unique fingerprint.

Cite this